Jagsonpal Pharmaceuticals Ltd
₹210.37
(0.74%)
Mon, 04 May 2026, 07:46 am
24.5KJagsonpal Pharmaceuticals Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
1411.94
Net Profit
55.36
P/B
5.99
Sector P/E
41.71
P/E
25.89
EV/EBITDA
16.65
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.69
ROCE (Industry)
13.46
RONW (Industry)
12.65
ROE
18.58
ROCE
22.82
Debt/Equity
0.04
EPS (TTM)
6.65
Dividend Yield
1.90
Book Value
41.14
Interest Cover
53.26
Analysis
all
- Dividends paid are thoroughly covered by earnings (14.2x coverage).
- Jagsonpal Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Jagsonpal Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Jagsonpal Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Jagsonpal Pharmaceuticals is profitable, therefore cash runway is not a concern.
- No dividend growth in 10 years.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Jagsonpal Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
- High level of physical assets or inventory.
- Jagsonpal Pharmaceuticals is not covered by any analysts.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 67.89 | 67.39 | 67.54 | 67.65 | 67.78 |
| FII | 2.44 | 2.12 | 2.12 | 2.18 | 2.10 |
| DII | 0.22 | 0.15 | 0.09 | 0.05 | 0.00 |
| Public | 29.45 | 30.34 | 30.25 | 30.12 | 30.11 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 262.09 | 232.39 | 221.38 | 202.69 | 191.68 | 172.99 | 143.29 |
| Fibonacci | 232.39 | 221.04 | 214.04 | 202.69 | 191.34 | 184.34 | 172.99 |
| Camarilla | 218.54 | 215.81 | 213.09 | 202.69 | 207.65 | 204.93 | 202.20 |
Pivots Level: Classic
R3
+59.40
262.09
R2
+29.70
232.39
R1
+18.69
221.38
S1
-11.01
191.68
S2
-29.70
172.99
S3
-59.40
143.29
Moving Average
Period
Value
10-EMA
202.88
20-EMA
197.83
30-EMA
194.22
50-EMA
190.47
100-EMA
191.81
200-EMA
199.76
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 27 Apr 2026 | board-meetings | Accounts, Final Dividend | |
| 12 Mar 2026 | buyback | ||
| 21 Jan 2026 | board-meetings | Quarterly Results | |
| 03 Nov 2025 | board-meetings | Quarterly Results | |
| 12 Aug 2025 | dividend | Final Dividend - Rs. - 2.5 | 12 Sept 2025 |
| 26 Jul 2025 | agm | ||
| 06 May 2025 | dividend | ₹2.50 Dividend /Share | 12 Sept 2025 |
| 08 Dec 2024 | dividend | Face Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per Share | 08 Jan 2025 |
| 08 Dec 2024 | split | Stock Split From Rs.5 to Rs.2 | 08 Jan 2025 |
| 23 Oct 2024 | split | 1:2.5 Splits of Equity Shares | 08 Jan 2025 |
Peer Comparison
Jagsonpal Pharmaceuticals Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Jagsonpal Pharmaceuticals Ltd About
Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1978
Headquarters
CEO
Harsha Raghavan
Employees
Contact
Website
http://www.jagsonpal.com
skmata@jagsonpal.com; cs@jagsonpal.com
Phone
91-011-46181100/46109900
Location
T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| HRTI PRIVATE LIMITED | Sell | 343628 | 293.5 | 28 Jul 2025 |
| HRTI PRIVATE LIMITED | Buy | 350647 | 293.56 | 28 Jul 2025 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 498300 | 293.68 | 28 Jul 2025 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 498300 | 294.1 | 28 Jul 2025 |
| ANKITA VISHAL SHAH | Sell | 154425 | 779.54 | 29 Nov 2024 |
| ANKITA VISHAL SHAH | Buy | 249425 | 775.17 | 29 Nov 2024 |
| INFINITY HOLDINGS | Sell | 2200000 | 400 | 13 Sept 2024 |
| INFINITY PORTFOLIO HOLDINGS | Buy | 2200000 | 400 | 13 Sept 2024 |
| J & P INVESTMENTS PARTNERSHIP | Sell | 225737 | 239.32 | 25 Feb 2022 |
| MANISH MAHESH GUPTA | Buy | 225067 | 239.32 | 25 Feb 2022 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800